Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Gemechu Churiso, Gose Husen, Denebo Bulbula & Lulu Abebe. (2022) Immunity Cell Responses to RSV and the Role of Antiviral Inhibitors: A Systematic Review. Infection and Drug Resistance 15, pages 7413-7430.
Read now
Read now
Anjali Sharma, Smritilekha Bera & Dhananjoy Mondal. (2022) Advances in the synthesis of antiviral agents from carbohydrate-derived chiral pools. Journal of Carbohydrate Chemistry 41:7-9, pages 424-510.
Read now
Read now
Marwa Ghazaly & Simon Nadel. (2018) Overview of prevention and management of acute bronchiolitis due to respiratory syncytial virus. Expert Review of Anti-infective Therapy 16:12, pages 913-928.
Read now
Read now
Patricia A Jorquera, Katie E Oakley & Ralph A Tripp. (2013) Advances in and the potential of vaccines for respiratory syncytial virus. Expert Review of Respiratory Medicine 7:4, pages 411-427.
Read now
Read now
Julia M Hussman, Abby Li, Bosco Paes & Krista L Lanctôt. (2012) A review of cost–effectiveness of palivizumab for respiratory syncytial virus. Expert Review of Pharmacoeconomics & Outcomes Research 12:5, pages 553-567.
Read now
Read now
Farnoosh Tayyari & Richard G Hegele. (2012) Identifying targets in the hunt for effective respiratory syncytial virus interventions. Expert Review of Respiratory Medicine 6:2, pages 215-222.
Read now
Read now
Articles from other publishers (61)
Abiodun Oladipo, Onome Ejeromedoghene, Ademola Adebayo, Olakunle Ogunyemi & George Egejuru. (2023)
A mini review on the prospects of
Fagara zanthoxyloides
extract based composites: a remedy for COVID-19 and associated replica?
. Physical Sciences Reviews 0:0.
Crossref
Crossref
Shiza Malik, Tahir Ahmad, Khalid Muhammad & Yasir Waheed. (2023) Respiratory Syncytial Virus Infection: Treatments and Clinical Management. Vaccines 11:2, pages 491.
Crossref
Crossref
Ann Colosia, Jessica Costello, Kelly McQuarrie, Kelly Kato & Kristi Bertzos. (2023) Systematic literature review of the signs and symptoms of respiratory syncytial virus. Influenza and Other Respiratory Viruses 17:2.
Crossref
Crossref
Dvir Gatt, Isaac Martin, Rawan AlFouzan & Theo J. Moraes. (2023) Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV). Pathogens 12:2, pages 154.
Crossref
Crossref
Tara C. Marcink, Janet A. Englund & Anne Moscona. 2020. Viral Infections of Humans. Viral Infections of Humans
1
50
.
Tara C. Marcink, Janet A. Englund & Anne Moscona. 2020. Viral Infections of Humans. Viral Infections of Humans
1
50
.
Xinrong Zhuang, Xuefeng Shen, Wensi Niu & Lingjun Kong. (2021) Disulfide-stapled design of α-helical bundles to target the trimer-of-hairpins motif of human respiratory syncytial virus fusion protein. Journal of Molecular Graphics and Modelling 108, pages 107984.
Crossref
Crossref
Tara C. Marcink, Matteo Porotto & Anne Moscona. 2021.
1
29
.
Jorge A. Soto, Nicolás M. S. Gálvez, Gaspar A. Pacheco, Susan M. Bueno & Alexis M. Kalergis. (2020) Antibody development for preventing the human respiratory syncytial virus pathology. Molecular Medicine 26:1.
Crossref
Crossref
Kirsten Stray, Michel Perron, Danielle P Porter, Francisco Anderson, Sandra A Lewis, Jason Perry, Michael Miller, Tomas Cihlar, John DeVincenzo, Jason W Chien & Robert Jordan. (2020) Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV. The Journal of Infectious Diseases 222:9, pages 1468-1477.
Crossref
Crossref
Jorge A. Soto, Laura M. Stephens, Kody A. Waldstein, Gisela Canedo-Marroquín, Steven M. Varga & Alexis M. Kalergis. (2020) Current Insights in the Development of Efficacious Vaccines Against RSV. Frontiers in Immunology 11.
Crossref
Crossref
Daniela Benítez‐Guerra, Cecilia Piña‐Flores, Miguel Zamora‐López, Francisco Escalante‐Padrón, Victoria Lima‐Rogel, Ana María González‐Ortiz, Marcela Guevara‐Tovar, Sofía Bernal‐Silva, Beatriz Benito‐Cruz, Fernanda Castillo‐Martínez, Luz E. Martínez‐Rodríguez, Vianney Ramírez‐Ojeda, Nallely Tello‐Martínez, Rodrigo Lomelí‐Valdez, Jack Salto‐Quintana, Sandra Cadena‐Mota & Daniel E. Noyola. (2020) Respiratory syncytial virus acute respiratory infection‐associated hospitalizations in preterm Mexican infants: A cohort study. Influenza and Other Respiratory Viruses 14:2, pages 182-188.
Crossref
Crossref
Cunsi Shen, Zhengguang Zhang, Tong Xie, Jianjian Ji, Jianya Xu, Lili Lin, Jing Yan, An Kang, Qigang Dai, Yingmei Dong, Jinjun Shan, Shouchuan Wang & Xia Zhao. (2020) Rhein Suppresses Lung Inflammatory Injury Induced by Human Respiratory Syncytial Virus Through Inhibiting NLRP3 Inflammasome Activation via NF-κB Pathway in Mice. Frontiers in Pharmacology 10.
Crossref
Crossref
Tom Solomon & Anna Maria Geretti. 2020. Hunter's Tropical Medicine and Emerging Infectious Diseases. Hunter's Tropical Medicine and Emerging Infectious Diseases
228
231
.
Joseph Domachowske, Jodi Halczyn & Cynthia A. Bonville. (2018) Preventing Pediatric Respiratory Syncytial Virus Infection. Pediatric Annals 47:9.
Crossref
Crossref
Polina German, Yan Xin, Jason W. Chien, Winnie Weng, Richard Mackman, Sandra A. Lewis, Amy Meng, John Ling & Anita Mathias. (2018) Phase 1 First-in-Human, Single- and Multiple-Ascending Dose, and Food Effect Studies to Assess the Safety, Tolerability, and Pharmacokinetics of Presatovir for the Treatment of Respiratory Syncytial Virus Infection. The Journal of Clinical Pharmacology 58:8, pages 1025-1034.
Crossref
Crossref
Katherine H. Restori, Bharat T. Srinivasa, Brian J. Ward & Elizabeth D. Fixman. (2018) Neonatal Immunity, Respiratory Virus Infections, and the Development of Asthma. Frontiers in Immunology 9.
Crossref
Crossref
Xiangxiang Shi, Jun Zheng & Tingting Yan. (2018) Computational redesign of human respiratory syncytial virus epitope as therapeutic peptide vaccines against pediatric pneumonia. Journal of Molecular Modeling 24:4.
Crossref
Crossref
Sonia Lorente Sánchez, Rebeca Gimeno, Josep-Maria Losilla, Sandra Garzón & Jaume Vives. (2018) Benefits of the humidified low-flow oxygen therapy in infants with mild-moderate bronchiolitis. Journal of Clinical Nursing 27:5-6, pages 1125-1133.
Crossref
Crossref
Paul C Jordan, Sarah K Stevens & Jerome Deval. (2018) Nucleosides for the treatment of respiratory RNA virus infections. Antiviral Chemistry and Chemotherapy 26, pages 204020661876448.
Crossref
Crossref
Q. Luo, X. Guo, S. Peng, W. Luo, F. Tian, P. Yu & Y. Zou. (2017)
The association between
MICA/MICB
polymorphism and respiratory syncytial virus infection in children
. International Journal of Immunogenetics 44:6, pages 328-336.
Crossref
Crossref
Daryll Vanover, Daisy V. Smith, Emmeline L. Blanchard, Eric Alonas, Jonathan L. Kirschman, Aaron W. Lifland, Chiara Zurla & Philip J. Santangelo. (2017) RSV glycoprotein and genomic RNA dynamics reveal filament assembly prior to the plasma membrane. Nature Communications 8:1.
Crossref
Crossref
Nam Nam Cheung, Kin Kui Lai, Jun Dai, Kin Hang Kok, Honglin Chen, Kwok-Hung Chan, Kwok-Yung Yuen & Richard Yi Tsun Kao. (2017) Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response. Journal of General Virology 98:5, pages 946-954.
Crossref
Crossref
Matthew W. McCarthy & Thomas J. Walsh. (2017) Prophylactic Measures During Induction for Acute Myeloid Leukemia. Current Oncology Reports 19:3.
Crossref
Crossref
Jesus Valdez, Swapnil Bawage, Idalia Gomez & Shree Ram Singh. (2016) Facile and rapid detection of respiratory syncytial virus using metallic nanoparticles. Journal of Nanobiotechnology 14:1.
Crossref
Crossref
Swapnil S. Bawage, Pooja M. Tiwari, Ankur Singh, Saurabh Dixit, Shreekumar R. Pillai, Vida A. Dennis & Shree R. Singh. (2016) Gold nanorods inhibit respiratory syncytial virus by stimulating the innate immune response. Nanomedicine: Nanotechnology, Biology and Medicine 12:8, pages 2299-2310.
Crossref
Crossref
Manel Essaidi-Laziosi, Matthieu Lyon, Aline Mamin, Mélanie Fernandes Rocha, Laurent Kaiser & Caroline Tapparel. (2016) A new real-time RT-qPCR assay for the detection, subtyping and quantification of human respiratory syncytial viruses positive- and negative-sense RNAs. Journal of Virological Methods 235, pages 9-14.
Crossref
Crossref
Rui Cui, Yizhuo Wang, Liu Wang, Guiming Li, Ke Lan, Ralf Altmeyer & Gang Zou. (2016) Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus. Antiviral Research 132, pages 38-45.
Crossref
Crossref
Sandra Cervantes-Ortiz, Natalia Zamorano Cuervo & Nathalie Grandvaux. (2016) Respiratory Syncytial Virus and Cellular Stress Responses: Impact on Replication and Physiopathology. Viruses 8:5, pages 124.
Crossref
Crossref
Xue-Feng Wang, Xiu-Ying Zhang, Xuejuan Gao, Xiao-Xue Liu & Yi-Huan Wang. (2016) Proteomic Profiling of a Respiratory Syncytial Virus-Infected Rat Pneumonia Model. Japanese Journal of Infectious Diseases 69:4, pages 285-292.
Crossref
Crossref
Zhao Liu, Nian Ma, Yan Zhong & Zhan-qiu Yang. (2015) Antiviral effect of emodin from Rheum palmatum against coxsakievirus B5 and human respiratory syncytial virus in vitro. Journal of Huazhong University of Science and Technology [Medical Sciences] 35:6, pages 916-922.
Crossref
Crossref
Seyhan Boyoglu-Barnum, Sean O. Todd, Tatiana Chirkova, Thomas R. Barnum, Kelsey A. Gaston, Lia M. Haynes, Ralph A. Tripp, Martin L. Moore & Larry J. Anderson. (2015) An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice. Virology 483, pages 117-125.
Crossref
Crossref
Leon Caly, Reena Ghildyal & David A. Jans. (2015) Respiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention?. Frontiers in Microbiology 6.
Crossref
Crossref
Sarah L. Noton, Kartikeya Nagendra, Ewan F. Dunn, Michael E. Mawhorter, Qin Yu & Rachel Fearns. (2015) Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter. Journal of Virology 89:15, pages 7786-7798.
Crossref
Crossref
Jan Schmutz, Tanja Manser, Julia Keil, Ellen Heimberg & Florian Hoffmann. (2015) Structured Performance Assessment in Three Pediatric Emergency Scenarios: A Validation Study. The Journal of Pediatrics 166:6, pages 1498-1504.e1.
Crossref
Crossref
Peter P. Wibroe, Shen Y. Helvig & S. Moein Moghimi. 2015. Antibodies for Infectious Diseases. Antibodies for Infectious Diseases
63
74
.
Clément Grandin, Marianne Lucas-Hourani, Marine Clavel, Fabrice Taborik, Astrid Vabret, Frédéric Tangy, Hugues Contamin & Pierre-Olivier Vidalain. (2015) Evidence for an intranasal immune response to human respiratory syncytial virus infection in cynomolgus macaques. Journal of General Virology 96:4, pages 782-792.
Crossref
Crossref
Fred Y. Aoki. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
531
545.e5
.
Craig Johnstone, Alison Hall & Ian J Hart. (2014) Common viral illnesses in intensive care: presentation, diagnosis, and management. Continuing Education in Anaesthesia Critical Care & Pain 14:5, pages 213-219.
Crossref
Crossref
Anna Krajczyk, Katarzyna Kulinska, Tadeusz Kulinski, Brett L Hurst, Craig W Day, Donald F Smee, Tomasz Ostrowski, Piotr Januszczyk & Joanna Zeidler. (2014) Antivirally Active Ribavirin Analogues – 4,5-disubstituted 1,2,3-triazole Nucleosides: Biological Evaluation against Certain Respiratory Viruses and Computational Modelling. Antiviral Chemistry and Chemotherapy 23:4, pages 161-171.
Crossref
Crossref
Gabriella Kiss, Jens M. Holl, Grant M. Williams, Eric Alonas, Daryll Vanover, Aaron W. Lifland, Manasa Gudheti, Ricardo C. Guerrero-Ferreira, Vinod Nair, Hong Yi, Barney S. Graham, Philip J. Santangelo & Elizabeth R. Wright. (2014) Structural Analysis of Respiratory Syncytial Virus Reveals the Position of M2-1 between the Matrix Protein and the Ribonucleoprotein Complex. Journal of Virology 88:13, pages 7602-7617.
Crossref
Crossref
Matti Kiupel & David Perpiñán. 2014. Biology and Diseases of the Ferret. Biology and Diseases of the Ferret
439
517
.
Peter P. Wibroe, Shen Y. Helvig & S. Moein Moghimi. (2014) The Role of Complement in Antibody Therapy for Infectious Diseases. Microbiology Spectrum 2:2.
Crossref
Crossref
Maria de Lourdes G. Ferreira, Luiz C. S. Pinheiro, Osvaldo A. Santos-Filho, Marta D. S. Peçanha, Carolina Q. Sacramento, Viviane Machado, Vitor F. Ferreira, Thiago Moreno L. Souza & Núbia Boechat. (2013) Design, synthesis, and antiviral activity of new 1H-1,2,3-triazole nucleoside ribavirin analogs. Medicinal Chemistry Research 23:3, pages 1501-1511.
Crossref
Crossref
Janet A. Englund & Anne Moscona. 2014. Viral Infections of Humans. Viral Infections of Humans
579
600
.
Tzeng-Jih Lin, Chia-Feng Yeh, Kuo-Chih Wang, Lien-Chai Chiang, Jih-Jin Tsai & Jung-San Chang. (2013) Water extract of Pueraria lobata Ohwi has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. The Kaohsiung Journal of Medical Sciences 29:12, pages 651-657.
Crossref
Crossref
Andrew T. Pavia. (2013) What is the Role of Respiratory Viruses in Community-Acquired Pneumonia?. Infectious Disease Clinics of North America 27:1, pages 157-175.
Crossref
Crossref
Fyza Y Shaikh & James E Crowe Jr. (2013) Molecular mechanisms driving respiratory syncytial virus assembly. Future Microbiology 8:1, pages 123-131.
Crossref
Crossref
Ágústa Gudmundsdóttir, Hilmar Hilmarsson & Bjarki Stefansson. (2013) Potential Use of Atlantic Cod Trypsin in Biomedicine. BioMed Research International 2013, pages 1-11.
Crossref
Crossref
Swapnil Subhash Bawage, Pooja Munnilal Tiwari, Shreekumar Pillai, Vida Dennis & Shree Ram Singh. (2013) Recent Advances in Diagnosis, Prevention, and Treatment of Human Respiratory Syncytial Virus. Advances in Virology 2013, pages 1-26.
Crossref
Crossref
Tom Solomon & Anna-Maria Geretti. 2013. Hunter's Tropical Medicine and Emerging Infectious Disease. Hunter's Tropical Medicine and Emerging Infectious Disease
213
216
.
Jean‐Christophe Le Bayon, Bruno Lina, Manuel Rosa‐Calatrava & Guy Boivin. (2012) Recent developments with live‐attenuated recombinant paramyxovirus vaccines. Reviews in Medical Virology 23:1, pages 15-34.
Crossref
Crossref
Hayat Caidi, Jennifer L. Harcourt, Ralph A. Tripp, Larry J. Anderson & Lia M. Haynes. (2012) Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice. PLoS ONE 7:12, pages e51485.
Crossref
Crossref
Joseph A. Sykes, Rajiv Verma, Courtney Peshkovsky, Brian O’Connor, Farhan Malik, Joseph Lubega, Sunil Malhotra, Derrick McQueen, Susmita Mikkilineni & Meena Kalyanaraman. (2012) Early Repair of Large Infant Ventricular Septal Defect Despite Respiratory Syncytial Virus–Induced Respiratory Failure With Postrepair Chylous Pericardial Effusion Requiring Pleuropericardial Window. Pediatric Emergency Care 28:10, pages 1072-1077.
Crossref
Crossref
H. Frickmann, S. Jungblut, T. O. Hirche, U. Groß, M. Kuhns & Andreas Erich Zautner. (2012) Spectrum of viral infections in patients with cystic fibrosis. European Journal of Microbiology and Immunology 2:3, pages 161-175.
Crossref
Crossref
Peter Rigaux, Kristin E. Killoran, Zhijun Qiu & Helene F. Rosenberg. (2012) Depletion of alveolar macrophages prolongs survival in response to acute pneumovirus infection. Virology 422:2, pages 338-345.
Crossref
Crossref
Burke A. Cunha, Uzma Syed & Jean E. Hage. (2012) Respiratory syncytial virus (RSV) community-acquired pneumonia (CAP) in a hospitalized adult with human immunodeficiency virus (HIV) mimicking influenza A and Pneumocystis (carinii) jiroveci pneumonia (PCP). Heart & Lung 41:1, pages 76-82.
Crossref
Crossref
Peter L. Collins & José A. Melero. (2011) Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years. Virus Research 162:1-2, pages 80-99.
Crossref
Crossref
Jan ter Meulen. (2011) Monoclonal Antibodies in Infectious Diseases: Clinical Pipeline in 2011. Infectious Disease Clinics of North America 25:4, pages 789-802.
Crossref
Crossref
Yoon Won Kim. (2011) The Development of Anti-inflammatory Drugs for Viral Diseases. Journal of Bacteriology and Virology 41:3, pages 209.
Crossref
Crossref
Nam Kyun KimJae Young Choi. (2011) Respiratory syncytial virus prevention in children with congenital heart disease: who and how?. Korean Journal of Pediatrics 54:5, pages 197.
Crossref
Crossref